Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,275 GBX | -0.35% | +1.44% | +15.96% |
02:05pm | ASTRAZENECA : Buy rating from JP Morgan | ZD |
13/05 | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.98% | 240B | |
+29.18% | 682B | |
+29.69% | 586B | |
-3.34% | 364B | |
+18.01% | 327B | |
+3.81% | 285B | |
+10.43% | 209B | |
-8.38% | 203B | |
+7.63% | 165B | |
-1.27% | 161B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Says New Drug Application for Breast Cancer Combination Therapy Granted Priority Review by US FDA